Testing effectiveness (Phase 2)UnknownNCT06224387
What this trial is testing
CTS2190 Phase I /II Clinical Study in Patients
Who this might be right for
Solid TumorsPancreatic CancerNon-small Cell Lung Cancer+1 more
CytosinLab Therapeutics Co., Ltd. 224